GB0221942D0 - Drug delivery - Google Patents

Drug delivery

Info

Publication number
GB0221942D0
GB0221942D0 GBGB0221942.6A GB0221942A GB0221942D0 GB 0221942 D0 GB0221942 D0 GB 0221942D0 GB 0221942 A GB0221942 A GB 0221942A GB 0221942 D0 GB0221942 D0 GB 0221942D0
Authority
GB
United Kingdom
Prior art keywords
drug delivery
relates
delivery
drugs
solubilising
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0221942.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Glasgow
University of Strathclyde
Original Assignee
University of Glasgow
University of Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Glasgow, University of Strathclyde filed Critical University of Glasgow
Priority to GBGB0221942.6A priority Critical patent/GB0221942D0/en
Publication of GB0221942D0 publication Critical patent/GB0221942D0/en
Priority to US10/528,602 priority patent/US20060148982A1/en
Priority to EP03748273A priority patent/EP1543063B1/en
Priority to CA002499681A priority patent/CA2499681A1/en
Priority to PCT/GB2003/004036 priority patent/WO2004026941A1/en
Priority to DE60326859T priority patent/DE60326859D1/de
Priority to AU2003267581A priority patent/AU2003267581A1/en
Priority to JP2004537295A priority patent/JP2006500437A/ja
Priority to SI200331599T priority patent/SI1543063T1/sl
Priority to DK03748273T priority patent/DK1543063T3/da
Priority to AT03748273T priority patent/ATE426635T1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
    • C08G73/0213—Preparatory process
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
    • C08G73/0213—Preparatory process
    • C08G73/0226—Quaternisation of polyalkylene(poly)amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
GBGB0221942.6A 2002-09-20 2002-09-20 Drug delivery Ceased GB0221942D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0221942.6A GB0221942D0 (en) 2002-09-20 2002-09-20 Drug delivery
AT03748273T ATE426635T1 (de) 2002-09-20 2003-09-22 Arzneimittelverabreichung
PCT/GB2003/004036 WO2004026941A1 (en) 2002-09-20 2003-09-22 Drug delivery
EP03748273A EP1543063B1 (en) 2002-09-20 2003-09-22 Drug delivery
CA002499681A CA2499681A1 (en) 2002-09-20 2003-09-22 Drug delivery
US10/528,602 US20060148982A1 (en) 2002-09-20 2003-09-22 Drug delivery
DE60326859T DE60326859D1 (de) 2002-09-20 2003-09-22 Arzneimittelverabreichung
AU2003267581A AU2003267581A1 (en) 2002-09-20 2003-09-22 Drug delivery
JP2004537295A JP2006500437A (ja) 2002-09-20 2003-09-22 薬物送達
SI200331599T SI1543063T1 (sl) 2002-09-20 2003-09-22 Dostava zdravila
DK03748273T DK1543063T3 (da) 2002-09-20 2003-09-22 Medikament levering

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0221942.6A GB0221942D0 (en) 2002-09-20 2002-09-20 Drug delivery

Publications (1)

Publication Number Publication Date
GB0221942D0 true GB0221942D0 (en) 2002-10-30

Family

ID=9944516

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0221942.6A Ceased GB0221942D0 (en) 2002-09-20 2002-09-20 Drug delivery

Country Status (11)

Country Link
US (1) US20060148982A1 (https=)
EP (1) EP1543063B1 (https=)
JP (1) JP2006500437A (https=)
AT (1) ATE426635T1 (https=)
AU (1) AU2003267581A1 (https=)
CA (1) CA2499681A1 (https=)
DE (1) DE60326859D1 (https=)
DK (1) DK1543063T3 (https=)
GB (1) GB0221942D0 (https=)
SI (1) SI1543063T1 (https=)
WO (1) WO2004026941A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422877D0 (en) * 2004-10-14 2004-11-17 Univ Glasgow Bioactive polymers
US8057821B2 (en) * 2004-11-03 2011-11-15 Egen, Inc. Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
JP5027157B2 (ja) 2006-01-19 2012-09-19 オールエクセル，インコーポレイティド 自己集合性の両親媒性ポリマーを有する薬物の可溶化および標的化導入
AU2007209376B2 (en) * 2006-01-27 2013-02-07 Basf Se Polymeric anti-microbial agents
US20090263346A1 (en) * 2006-12-05 2009-10-22 David Taft Systems and methods for delivery of drugs
US8956602B2 (en) * 2006-12-05 2015-02-17 Landec, Inc. Delivery of drugs
US8399007B2 (en) * 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US20100004124A1 (en) * 2006-12-05 2010-01-07 David Taft Systems and methods for delivery of materials for agriculture and aquaculture
US20090246155A1 (en) * 2006-12-05 2009-10-01 Landec Corporation Compositions and methods for personal care
PL2126020T3 (pl) * 2006-12-22 2012-04-30 Basf Se Hydrofobowo modyfikowane polialkilenoiminy jako inhibitory przenoszenia barwnika
CN101795695B (zh) * 2007-07-19 2016-01-06 阿列克斯塞尔公司 作为抗癌剂的自组装的两亲性聚合物
US8114883B2 (en) * 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
FR2928373B1 (fr) 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
GB0903559D0 (en) 2009-03-02 2009-04-08 Univ London Pharmacy Oral delivery of hydrophilic drugs to the brain
EP2424581B1 (en) 2009-04-28 2017-03-01 SurModics, Inc. Devices and methods for delivery of bioactive agents
GB0915449D0 (en) 2009-09-04 2009-10-07 Univ Robert Gordon Composition
DK2563843T3 (en) 2010-04-28 2018-03-12 Univ Georgia PHOTOCHEMICAL CROSS-POLYMERS, PROCEDURES FOR MARKING PHOTOCHEMIC CROSS-POLYMERS, PROCEDURES FOR USING PHOTOCHEMIC CROSS-POLYMERS, AND ...
US8721936B2 (en) 2011-04-21 2014-05-13 University Of Georgia Research Foundation, Inc. Devices and methods for forming non-spherical particles
US10213529B2 (en) 2011-05-20 2019-02-26 Surmodics, Inc. Delivery of coated hydrophobic active agent particles
US9861727B2 (en) 2011-05-20 2018-01-09 Surmodics, Inc. Delivery of hydrophobic active agent particles
CA2841000C (en) 2011-07-15 2020-02-25 University Of Georgia Research Foundation, Inc. Permanent attachment of agents to surfaces containing c-h functionality
WO2013019918A2 (en) 2011-08-04 2013-02-07 The University Of Georgia Research Foundation, Inc. Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing-oh functionality
US9839213B2 (en) 2011-10-14 2017-12-12 The University Of Georgia Research Foundation, Inc. Photochemical cross-linkable polymers, methods of making photochemical cross-linkable polymers, methods of using photochemical cross-linkable polymers, and methods of making articles containing photochemical cross-linkable polymers
WO2014071387A1 (en) 2012-11-05 2014-05-08 Surmodics, Inc. Composition and method for delivery of hydrophobic active agents
US11246963B2 (en) 2012-11-05 2022-02-15 Surmodics, Inc. Compositions and methods for delivery of hydrophobic active agents
US10898446B2 (en) 2016-12-20 2021-01-26 Surmodics, Inc. Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces
US12226552B2 (en) 2019-09-30 2025-02-18 Surmodics, Inc. Active agent depots formed in situ

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5879022A (ja) * 1981-11-04 1983-05-12 Bitamin Kenkyusho:Kk 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤
US5338532A (en) * 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
US5681543A (en) * 1988-02-29 1997-10-28 Shering Aktiengesellschaft Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI
JPH01236240A (ja) * 1989-01-14 1989-09-21 Miyoshi Oil & Fat Co Ltd 新規な高分子化合物
DE3901527A1 (de) * 1989-01-20 1990-07-26 Hoechst Ag Alkylierte polyethyleniminderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate
JP3406970B2 (ja) * 1993-12-27 2003-05-19 ミヨシ油脂株式会社 両性界面活性剤
JP3526661B2 (ja) * 1995-06-23 2004-05-17 ミヨシ油脂株式会社 抗菌剤、抗菌性樹脂及び抗菌性塗料
BR9709830A (pt) * 1996-06-19 1999-08-10 Procter & Gamble Perocesso para remoção de maus cheiros de poliaminas modificadas
WO1999043752A1 (fr) * 1998-02-27 1999-09-02 Dnavec Research Inc. Compositions pour transporter des substances chargees negativement
JP3523821B2 (ja) * 2000-02-09 2004-04-26 ナノキャリア株式会社 薬物が封入されたポリマーミセルの製造方法および該ポリマーミセル組成物
US6696038B1 (en) * 2000-09-14 2004-02-24 Expression Genetics, Inc. Cationic lipopolymer as biocompatible gene delivery agent
CN1479632A (zh) * 2000-10-09 2004-03-03 用于将核酸导入细胞的复合物
DE10065710A1 (de) * 2000-12-29 2002-07-04 Bayer Ag Arzneimittel enthaltend ein Polyamin als Wirksubstanz
GB0221941D0 (en) * 2002-09-20 2002-10-30 Univ Strathclyde Polysoaps

Also Published As

Publication number Publication date
EP1543063B1 (en) 2009-03-25
DE60326859D1 (de) 2009-05-07
EP1543063A1 (en) 2005-06-22
US20060148982A1 (en) 2006-07-06
SI1543063T1 (sl) 2009-08-31
AU2003267581A1 (en) 2004-04-08
AU2003267581A8 (en) 2004-04-08
JP2006500437A (ja) 2006-01-05
ATE426635T1 (de) 2009-04-15
WO2004026941A1 (en) 2004-04-01
DK1543063T3 (da) 2009-05-18
CA2499681A1 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
GB0221942D0 (en) Drug delivery
WO2006060547A3 (en) Systems and methods for intra-oral drug delivery
IL215981A0 (en) An antibody-drug conjugate, an article or manufacture and pharmaceutical compositions comprising thereof
WO2003011226A3 (en) Products and drug delivery vehicles
TW200605870A (en) Topical methadone compositions and methods for using the same
TW200616589A (en) Transdermal delivery of drugs based on crystal size
AU2003266133A1 (en) Materials and methods for drug delivery and uptake
AP2002002558A0 (en) Pharmaceutical compositions containing polymer and drug assemblies.
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
WO2001012199A3 (en) Methoxyamine potentiation of temozolomide anti-cancer activity
EA200600877A1 (ru) Наночастицы для доставки лекарств
EP1513825A4 (en) ANTITU-CULINARY MEDICAMENT: COMPOSITIONS AND METHODS
EP1611880A3 (en) Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
DE60327693D1 (de) Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff
UY27929A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
EP1783137A4 (en) GALACTOSIS DERIVATIVE, DRUG VECTOR AND THERAPEUTIC PREPARATION
SI1909843T1 (sl) Protitumorski biokonjugati hialuronske kisline ali njenih derivatov, dobljeni z indirektno kemijsko konjugacijo, in njihova uporaba na farmacevtskem področju
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
CY1105211T1 (el) Φαρμακευτικοι συνδυασμοι που πepιλαμβανουν εναν ανταγωνιστη του υποδοχεα p2τ και μελαγατρανη
WO2006124681A3 (en) Oral drug delivery system and methods of use thereof
EP1848418A4 (en) USE OF NORDIHYDROGUAIARETIC ACID DERIVATIVES FOR THE TREATMENT OF DRUG RESISTANT VIRAL AND MICROBIAL CANCERS AND INFECTIONS
EA200970353A1 (ru) Комбинированное лекарственное средство

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)